Pharmacy Research Institutesp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-12-07
Share capital
500 000,00 PLN
Activity description

Pharmacy Research Institute operates in research, development and pharmaceuticals. The company’s headquarters are in Poznań at 332 Bukowska Street.

Registered address
ul. Bukowska 332, 60-189 Poznań, Poland
Website
pharmacyinstitute.plWebsite active
Email
Email warning
Phone
Electronic delivery address
AE:PL-75124-61647-VRHUR-23

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 294.41kMedianUSD 126.89kAverageUSD 4.67m
Net profit
This companyUSD -5.82kMedianUSD -19.64AverageUSD 371.62k
Operating costs
This companyUSD 300.22kMedianUSD 165.83kAverageUSD 4.01m
Assets
This companyUSD 666.68kMedianUSD 251.40kAverageUSD 7.40m

Bank accounts

Registered as a VAT taxpayer on 2020-02-12. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

4 public aid cases recorded, with a total value of $1,234,886.

PurposeGross amount
Aid for research and development projects: industrial research
$988.6K
Aid for research and development projects: experimental development
$177.0K
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$67,951

European Funds

ProjectEU co-financing
Prace badawczo – rozwojowe nad nową gamą preparatów kosmeceutycznych wykorzystujących substancje czynne pochodzenia naturalnego o zwiększonej penetracji w głąb skóry oraz właściwościach regenerujących i ochronnych.
$1.2M

Tenders

No recorded participation in tenders.

Authorized Representatives

Piotr Pospieszny — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
4,750$128,309.0295%
Others
250$6,753.115%

Beneficial owners

Person
Wojciech Jerzy Winkel (51)

Competitors

Name
Aurevia Polandsp. z o.o.
BiokineticaS.A.
Orphinic ScientificS.A.
Medicofarma BiotechS.A.
TCIsp. z o.o.
Pharmaxi Polandsp. z o.o.
OPESsp. z o.o.
New Valuesp. z o.o.
Biostat Research And Developmentsp. z o.o.
Zawamedsp. z o.o.

Change history

DateEvent
2025-09-29PKD change
2024-04-12Address change
2021-12-28Address change
2019-12-07Entered in the register

FAQ

Last updated: 2026-07-04